IceCure Medical Statistics

Total Valuation

IceCure Medical has a market cap or net worth of $22.21 million. The enterprise value is $14.38 million.

Market Cap	22.21M
Enterprise Value	14.38M

Important Dates

The next estimated earnings date is Wednesday, May 27, 2026, before market open.

Earnings Date	May 27, 2026
Ex-Dividend Date	n/a

Share Statistics

IceCure Medical has 81.18 million shares outstanding. The number of shares has increased by 24.97% in one year.

Current Share Class	81.18M
Shares Outstanding	81.18M
Shares Change (YoY)	+24.97%
Shares Change (QoQ)	+11.05%
Owned by Insiders (%)	46.07%
Owned by Institutions (%)	0.70%
Float	43.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.82
Forward PS	2.85
PB Ratio	2.29
P/TBV Ratio	2.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.02.

Current Ratio	2.61
Quick Ratio	1.96
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -188.78% and return on invested capital (ROIC) is -113.47%.

Return on Equity (ROE)	-188.78%
Return on Assets (ROA)	-71.29%
Return on Invested Capital (ROIC)	-113.47%
Return on Capital Employed (ROCE)	-166.53%
Weighted Average Cost of Capital (WACC)	17.93%
Revenue Per Employee	$48,971
Profits Per Employee	-$218,217
Employee Count	69
Asset Turnover	0.26
Inventory Turnover	0.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.20% in the last 52 weeks. The beta is 2.52, so IceCure Medical's price volatility has been higher than the market average.

Beta (5Y)	2.52
52-Week Price Change	-77.20%
50-Day Moving Average	0.49
200-Day Moving Average	0.73
Relative Strength Index (RSI)	28.30
Average Volume (20 Days)	589,362

Short Selling Information

The latest short interest is 1.31 million, so 1.61% of the outstanding shares have been sold short.

Short Interest	1.31M
Short Previous Month	1.41M
Short % of Shares Out	1.61%
Short % of Float	2.99%
Short Ratio (days to cover)	1.58

Income Statement

In the last 12 months, IceCure Medical had revenue of $3.38 million and -$15.06 million in losses. Loss per share was -$0.24.

Revenue	3.38M
Gross Profit	1.23M
Operating Income	-15.09M
Pretax Income	-15.06M
Net Income	-15.06M
EBITDA	-14.80M
EBIT	-15.09M
Loss Per Share	-$0.24

Full Income Statement

Balance Sheet

The company has $8.90 million in cash and $217,000 in debt, giving a net cash position of $8.68 million or $0.11 per share.

Cash & Cash Equivalents	8.90M
Total Debt	217,000
Net Cash	8.68M
Net Cash Per Share	$0.11
Equity (Book Value)	9.05M
Book Value Per Share	0.12
Working Capital	7.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.57 million and capital expenditures -$36,000, giving a free cash flow of -$14.61 million.

Operating Cash Flow	-14.57M
Capital Expenditures	-36,000
Depreciation & Amortization	295,000
Net Borrowing	n/a
Free Cash Flow	-14.61M
FCF Per Share	-$0.18

Full Cash Flow Statement

Margins

Gross Margin	36.28%
Operating Margin	-446.70%
Pretax Margin	-445.61%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IceCure Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.97%
Shareholder Yield	-24.97%
Earnings Yield	-65.31%
FCF Yield	-63.37%

Analyst Forecast

The average price target for IceCure Medical is $2.50, which is 813.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.50
Price Target Difference	813.74%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	62.02%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IceCure Medical has an Altman Z-Score of -7.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.04
Piotroski F-Score	3